tert-Butyl 4-methoxybenzylcarbamate

Catalog No. :
ACGIPN594
CAS No. :
120157-94-0
Molecular Formula :
C13H19NO3
Molecular Weight :
237.30

IUPAC Name:tert-butyl (4-methoxybenzyl)carbamate

tert-Butyl 4-methoxybenzylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$135.00Login to see priceIn stockInquiry
250mg95%$224.00Login to see priceIn stockInquiry
1g95%$558.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-methoxybenzylcarbamate
IUPAC Nametert-butyl (4-methoxybenzyl)carbamate
MDL No.MFCD21105772
Molecular FormulaC13H19NO3
Molecular Weight237.30
SMILESO=C(NCC1=CC=C(C=C1)OC)OC(C)(C)C
InChI KeyOVAFZCTWIMXZLF-UHFFFAOYSA-N
Synonymtert-butyl 4-methoxybenzylcarbamate;TERT-BUTYL 4-METHOXYBENZYLCARBAMATE(WXC08687);Carbamic acid, N-[(4-methoxyphenyl)methyl]-, 1,1-dimethylethyl ester;N-Boc-1-(4-methoxyphenyl)methanamine;1,1-Dimethylethyl N-[(4-methoxyphenyl)methyl]carbamate
CAS No.120157-94-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGIPN594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIPN594 route product structure diagram
    ACGIPN594120157-94-0 In Stock
Inquiry

2. ACGIPN594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIPN594 route product structure diagram
    ACGIPN594120157-94-0 In Stock
Inquiry

Comments (0)